Vitality Biopharma Inc (OTCMKTS:VBIO) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.35 and traded as high as $0.23. Vitality Biopharma shares last traded at $0.22, with a volume of 1,403 shares.
The company has a current ratio of 4.08, a quick ratio of 4.08 and a debt-to-equity ratio of 0.03. The stock has a fifty day simple moving average of $0.22 and a 200-day simple moving average of $0.34.
About Vitality Biopharma (OTCMKTS:VBIO)
Vitality Biopharma, Inc engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions.
Read More: What are municipal bonds?
Receive News & Ratings for Vitality Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitality Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.